圣诺医药-B拟折价近20%配股总筹2.08亿港元，华熙生物等参与认购

Core Viewpoint - Saint Noble Pharmaceuticals-B (02257.HK) announced a subscription agreement for the issuance of 17.3524 million shares at a subscription price of HKD 12.00 per share, representing a discount of approximately 19.84% from the last trading price of HKD 14.97 on September 5 [1] Group 1 - The total number of subscription shares represents about 16.50% of the company's existing issued share capital as of the announcement date [1] - After the issuance of all subscription shares, the enlarged issued share capital will be approximately 14.16% [1] - The total proceeds from the subscription are expected to be around HKD 208.2 million, with a net amount of approximately HKD 206 million [1] Group 2 - The subscribers include Huaxi Biotechnology (Hong Kong) Co., Ltd., Mr. Xie Shuohao, Bamboo Bloom Limited, and Capstone Resources Holding Limited [1] - The proceeds from the subscription will be used for general working capital of the group [1]